Search results for "Stimulant(s)"

showing 10 items of 76 documents

Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients – Results of the COMPAS Study

2020

Abstract Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study (COMPAS) was a prospective, randomized multicenter clinical trial, comparing methylphenidate (MPH) with placebo (PLAC) in combination with cognitive behavioral group psychotherapy (GPT) or individual clinical management (CM) over the period of 1 year. Here, we report results on treatment safety. Methods MPH and PLAC were flexibly dosed. Among 433 randomized patients, adverse events (AEs) were documented and analyzed on an “as received” basis during week 0–52. Electrocardiogram data were recorded at baseline and week 24. Results Comparing 205 patients who received ≥1 dose of MPH with 209 patients wh…

AdultMaleTachycardiamedicine.medical_specialtyAdolescentDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentMedizin610 Medicine & healthPlaceboGroup psychotherapyYoung Adult2738 Psychiatry and Mental Health03 medical and health sciences0302 clinical medicineDouble-Blind MethodInternal medicinemedicinePalpitationsHumans2736 Pharmacology (medical)Pharmacology (medical)Prospective StudiesAdverse effectCognitive Behavioral TherapyHyperhidrosisMethylphenidatebusiness.industryGeneral MedicineMiddle AgedCombined Modality Therapy3. Good health030227 psychiatryClinical trialPsychiatry and Mental healthAttention Deficit Disorder with Hyperactivity10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsMethylphenidateCentral Nervous System StimulantsFemalePatient Safetymedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugPharmacopsychiatry
researchProduct

Life context of pharmacological academic performance enhancement among university students – a qualitative approach

2014

Background Academic performance enhancement or cognitive enhancement (CE) via stimulant drug use has received increasing attention. The question remains, however, whether CE solely represents the use of drugs for achieving better academic or workplace results or whether CE also serves various other purposes. The aim of this study was to put the phenomenon of pharmacological academic performance enhancement via prescription and illicit (psycho-) stimulant use (Amphetamines, Methylphenidate) among university students into a broader context. Specifically, we wanted to further understand students’ experiences, the effects of use on students and other factors, such as pressure to perform in thei…

AdultMaleUniversitiesSubstance-Related Disorders610 MedizinStimulantsHealth(social science)Cognition610 Medical sciencesHumansStudentsNootropic AgentsQualitative ResearchLife impactEthicsMotivationHealth PolicyAmphetaminesUniversity studentsIssues ethics and legal aspectsAttitudesAcademic performance enhancementMethylphenidateEducational StatusCentral Nervous System StimulantsFemaleResearch ArticleCognitive enhancementBMC Medical Ethics
researchProduct

A fatal paramethoxymethamphetamine intoxication.

2003

During the last years in Germany a marked increase in the use of amphetamines such as 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has been observed. The use of these recreational drugs is especially common among young people participating in rave parties. Occasionally ring-methoxylated phenethylamine derivatives like paramethoxymethamphetamine (PMMA) or paramethoxyamphetamine (PMA) are found in street drugs offered as ecstasy. These compounds exhibit a higher toxicity than the methylenedioxyamphetamine derivatives. We report on the death of a 22-year-old man after the ingestion of ecstasy pills containing PMMA and PMA. The PMMA concentration in femoral blood was 0.85 mg/l. Besides PMA…

AdultMalemedicine.drug_classEcstasyPharmacologyGas Chromatography-Mass SpectrometryPathology and Forensic MedicineMethamphetaminechemistry.chemical_compoundCocaineDopamine Uptake InhibitorsmedicineIngestionHumansAmphetamineChromatography High Pressure LiquidEthanolbusiness.industryIllicit DrugsAmphetaminesForensic toxicologyCentral Nervous System DepressantsMDMADesigner drugIssues ethics and legal aspectsAmphetaminechemistryPillBenzoylecgonineCentral Nervous System Stimulantsbusinessmedicine.drugLegal medicine (Tokyo, Japan)
researchProduct

Effect of caffeine on simulator flight performance in sleep-deprived military pilot students.

2007

Caffeine has been suggested to act as a countermeasure against fatigue in military operations. In this randomized, double-blind, placebo-controlled study, the effect of caffeine on simulator flight performance was examined in 13 military pilots during 37 hours of sleep deprivation. Each subject performed a flight mission in simulator four times. The subjects received either a placebo (six subjects) or 200 mg of caffeine (seven subjects) 1 hour before the simulated flights. A moderate 200 mg intake of caffeine was associated with higher axillary temperatures, but it did not affect subjectively assessed sleepiness. Flight performance was similar in both groups during the four rounds flown und…

AdultMalemedicine.medical_specialtyAircraftPoison controlPlaceboFlight simulatorlaw.inventionAviation safetychemistry.chemical_compoundRandomized controlled trialDouble-Blind MethodlawCaffeineMedicineHumansWakefulnessSimulationbusiness.industryPublic Health Environmental and Occupational HealthGeneral MedicineSleep deprivationMilitary PersonnelchemistryAerospace MedicineSleep DeprivationCentral Nervous System StimulantsAviation medicinemedicine.symptombusinessCaffeinePsychomotor PerformanceFollow-Up StudiesMilitary medicine
researchProduct

Nonmedical use of prescription drugs in the European Union

2016

Background Nonmedical prescription drug use (NMPDU) refers to the self-treatment of a medical condition using medication without a prescriber’s authorization as well as use to achieve euphoric states. This article reports data from a cross-national investigation of NMPDU in five European Countries, with the aim to understand the prevalence and characteristics of those engaging in NMPDU across the EU. Methods A parallel series of self-administered, cross-sectional, general population surveys were conducted in 2014. Data were collected using multi-stage quota sampling and then weighted using General Exponential Model. A total of 22,070 non-institutionalized participants, aged 12 to 49 years, …

AdultMalemedicine.medical_specialtyPrescription drugPrescription DrugsCross-sectional studySubstance-Related Disordersmedicine.medical_treatmentDenmarkPopulationPharmacyThinking03 medical and health sciencesYoung Adult0302 clinical medicineRisk FactorsGermanymedicinePrevalencemedia_common.cataloged_instanceHypnotics and SedativesHumans030212 general & internal medicineEuropean UnionEuropean unionMedical prescriptionPsychiatryeducationPrescription Drug MisuseReproductive healthmedia_commonSwedeneducation.field_of_studybusiness.industryUnited KingdomStimulantAnalgesics OpioidEuropePsychiatry and Mental healthCross-Sectional StudiesSpainCentral Nervous System StimulantsFemalebusiness030217 neurology & neurosurgeryResearch ArticleBMC Psychiatry
researchProduct

Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.

2019

Key Points Question What are the long-term results of multimodal treatment for adult attention-deficit/hyperactivity disorder (ADHD) when comparing cognitive behavioral group psychotherapy (GPT) with individual clinical management (CM) in combination with either methylphenidate or placebo? Findings In this follow-up assessment of the Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS), a multicenter randomized clinical trial, 256 adults participated in follow-up 1.5 years after the intervention ended. The severity of ADHD symptoms improved in all 4 prior treatment groups, with no significant difference found between GPT and CM, but methylphenidate was associated wit…

AdultMalemedicine.medical_specialtyRandomizationMedizinPlacebolaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled triallawRating scalemental disordersmedicineAttention deficit hyperactivity disorderHumansYoung adultOriginal InvestigationPsychiatryCognitive Behavioral Therapybusiness.industryResearchBeck Depression InventoryGeneral MedicineMiddle Aged16. Peace & justicemedicine.diseaseCombined Modality Therapy030227 psychiatry3. Good healthOnline OnlyTreatment OutcomeAttention Deficit Disorder with HyperactivityPhysical therapyClinical Global ImpressionMethylphenidateCentral Nervous System StimulantsFemalebusiness030217 neurology & neurosurgeryFollow-Up StudiesJAMA network open
researchProduct

Sleepiness, sleep, and use of sleepiness countermeasures in shift-working long-haul truck drivers

2015

Driver sleepiness is a prevalent phenomenon among professional drivers working unconventional and irregular hours. For compromising occupational and traffic safety, sleepiness has become one of the major conundrums of road transportation. To further elucidate the phenomenon, an on-road study canvassing the under-explored relationship between working hours and sleepiness, sleep, and use of sleepiness countermeasures during and outside statutory rest breaks was conducted. Testing the association between the outcomes and working hours, generalized estimating equations models were fitted on a data collected from 54 long-haul truck drivers (mean 38.1 ± 10.5 years, one female) volunteering in the…

AdultMalemedicine.medical_specialtySleepinessEveningShift workPoison controlTransportationHuman Factors and ErgonomicsComputer securitycomputer.software_genreCoffeeOccupational safety and healthShift workOn-road studySleep Disorders Circadian RhythmCaffeineSurveys and QuestionnairesWork Schedule ToleranceOdds RatioHumansMedicineAttentionOccupationsSocial BehaviorSafety Risk Reliability and Qualityta515FinlandRoad transportationMorningbusiness.industryAccidents TrafficPublic Health Environmental and Occupational HealthActigraphyta3142Middle AgedConfidence intervalSleepiness countermeasureMotor VehiclesAlertnessPhysical therapyCentral Nervous System StimulantsFemaleSleepbusinesscomputerAccident Analysis & Prevention
researchProduct

Distinguishing Comorbidity and Successful Management of Adult ADHD

2012

Objective: Given high rates of comorbidity, lack of awareness and global acceptance, and varying guidelines for its management, adult ADHD may be an especially difficult condition to diagnose and treat. The objective of this review was to explore and characterize similarities and differences among comorbidities associated with adult ADHD. Method: A review of the literature over the past 10 years was performed using Ovid. Results: A myriad of comorbid conditions such as impulse-control/personality, anxiety, mood, substance use, learning, and sleep disorders overlap with adult ADHD. Furthermore, a number of such conditions have symptoms that can mimic those of ADHD, including hyperactivity, …

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectmedicine.medical_treatmentPoison controlComorbidityImpulsivitybehavioral disciplines and activitiesSex Factorsmental disordersInjury preventionPrevalenceDevelopmental and Educational PsychologymedicineHumansPersonalityPsychiatrymedia_commonMental Disordersmedicine.diseaseComorbidityStimulantClinical PsychologyMoodAttention Deficit Disorder with HyperactivityAnxietyCentral Nervous System StimulantsFemalemedicine.symptomPsychologyClinical psychologyJournal of Attention Disorders
researchProduct

Effectiveness of Psychotherapy in Adult ADHD: What Do Patients Think? Results of the COMPAS Study

2017

Objective: In the multicenter study Comparison of Methylphenidate and Psychotherapy in Adult ADHD (COMPAS), the efficacy of treatments has been primarily evaluated by observer-rated symptom change. Here, we additionally analyzed the patients’ subjective evaluation of therapy effects. Method: COMPAS compared ADHD-specific group therapy with unspecific clinical management with/without concomitant pharmacotherapy in a four-armed design. Evaluation through the patients’ retrospective perspective was performed after 1 year (post-treatment) and after another 1.5 years (follow-up). Results: In respect to patients’ subjective ratings, ADHD-specific group psychotherapy outperformed unspecific manage…

AdultMindfulnessPsychotherapistmedicine.medical_treatmentMedizinGroup psychotherapy03 medical and health sciences0302 clinical medicinePharmacotherapyDevelopmental and Educational PsychologymedicineHumans0501 psychology and cognitive sciencesRetrospective StudiesTherapy EvaluationMethylphenidate05 social sciences3. Good healthClinical PsychologyTreatment OutcomeMulticenter studyAttention Deficit Disorder with HyperactivityConcomitantMethylphenidatePsychotherapy GroupCentral Nervous System StimulantsPsychology030217 neurology & neurosurgery050104 developmental & child psychologyClinical psychologymedicine.drug
researchProduct

Clinical Recognition and Management of Adult Attention Deficit Hyperactivity Disorder

1996

Adults with attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) are a new phenomenon to many health care providers. While increasing evidence indicates children with ADD/ADHD can have persistent problems into adulthood, the significance and management of these disorders for adults are poorly understood. Studies of adults are confounded by frequent comorbidity with other conditions and by retrospective diagnosis of childhood ADD/ADHD. Research studies of pharmacologic interventions do not indicate a clear pattern of efficacy and safety for any drug class. Pharmacologic treatment of adults with ADD/ADHD is often guided by clinical experience. Efficacy of treat…

AdultReferralbusiness.industryMEDLINEmedicine.diseaseImpulsivitybehavioral disciplines and activitiesComorbidityAntidepressive AgentsDiagnosis DifferentialPsychotherapyInterpersonal relationshipDrug classAttention Deficit Disorder with Hyperactivitymental disordersHealth carePrevalencemedicineHumansAttention deficit hyperactivity disorderCentral Nervous System Stimulantsmedicine.symptombusinessGeneral NursingClinical psychologyThe Nurse Practitioner
researchProduct